By Mill Chart
Last update: Apr 18, 2025
Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if HALOZYME THERAPEUTICS INC (NASDAQ:HALO) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted HALOZYME THERAPEUTICS INC showing up in our growth with base formation screen, so it may be worth spending some more time on it.
A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. HALO has received a 8 out of 10:
ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. HALO was assigned a score of 8 for health:
ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. HALO scores a 8 out of 10:
ChartMill also assigns a Setup Rating to each stock. This rating, on a scale of 0 to 10, reflects the degree of consolidation observed based on short-term technical indicators. Currently, HALO exhibits a 7 setup rating, indicating its consolidation status in recent days and weeks.
Besides having an excellent technical rating, HALO also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 59.13. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 58.78, a Stop Loss order could be placed below this zone.
More Strong Growth stocks can be found in our Strong Growth screener.
For an up to date full fundamental analysis you can check the fundamental report of HALO
Check the latest full technical report of HALO for a complete technical analysis.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
NASDAQ:HALO (7/1/2025, 2:31:07 PM)
52.825
+0.8 (+1.55%)
Find more stocks in the Stock Screener
HALOZYME THERAPEUTICS (NASDAQ:HALO) offers strong growth, solid profitability, and reasonable valuation, making it a standout in affordable growth investing.
HALOZYME THERAPEUTICS (NASDAQ:HALO) offers a rare mix of strong growth, profitability, and financial health at an attractive valuation, making it a standout in the biotech sector.
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) shows strong growth fundamentals and a potential technical breakout, making it a stock to watch in the biotech sector.